ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver

ClinicalTrials.gov ID: NCT00803647

Public ClinicalTrials.gov record NCT00803647. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 3:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study to Determine the Surgical Conversion Rate in Patients Receiving Neoadjuvant mFOLFOX7 + Cetuximab for Unresectable Wild-Type K-RAS Colorectal Cancer With Metastases Confined to the Liver

Study identification

NCT ID
NCT00803647
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
NSABP Foundation Inc
Network
Enrollment
20 participants

Conditions and interventions

Interventions

  • 5-FU Drug
  • cetuximab Biological
  • leucovorin Drug
  • oxaliplatin Drug

Drug · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2009
Primary completion
Jun 30, 2013
Completion
Oct 31, 2014
Last update posted
Oct 5, 2021

2010 – 2014

United States locations

U.S. sites
23
U.S. states
14
U.S. cities
21
Facility City State ZIP Site status
Loma Linda University Medical Center Loma Linda California 92354
St. Joseph Hospital Orange California 92868
Kaiser Permanente-San Diego San Diego California 92120
Kaiser Permanente Medical Center - Vallejo Vallejo California 94589
CCOP - Christiana Care Health Services Newark Delaware 19718
M.D. Anderson Cancer Center - Orlando Orlando Florida 32806
CCOP - NorthShore University HealthSystem Evanston Illinois 60201
Edward Hospital Naperville Illinois 60566
University of Iowa Iowa City Iowa 52242
NortonHealthcare, Inc. Louisville Kentucky 40202-5070
Franklin Square Hospital Center Baltimore Maryland 21237
Henry Ford Health System Detroit Michigan 48202
CCOP - Grand Rapids Clinical Oncology Program Grand Rapids Michigan 49503
CCOP, William Beaumont Hospital Royal Oak Michigan 48073
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
CCOP, Dayton, OH Dayton Ohio 45420
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
Allegheny Cancer Center at Allegheny General Hospital Pittsburgh Pennsylvania 15212
NSABP Foundation, Inc. Pittsburgh Pennsylvania 15212
University of Pittsburgh Pittsburgh Pennsylvania 15232-1305
CCOP - Upstate Carolina Spartanburg South Carolina 29303
Vermont Cancer Center at University of Vermont Burlington Vermont 05405-0075
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00803647, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 5, 2021 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00803647 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →